Boughanim M, Leboulleux S, Rey A, et al. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]ﬂuorodeoxyglucose positron emission tomography scans in the para-aortic area. J Clin Oncol 2008;26:2558–2561 142.
Haie C, Pejovic MH, Gerbaulet A, et al. Is prophylactic paraaortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. Radiother Oncol 1998;11:101.
143.
Rotman M, Pajak TF, Choi K, et al. Prophylactic extended-field irradiation of paraaortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995;274:387.
144.
Stehman FB, Bundy BN, Hanjani P, et al. Biopsy of the scalene fat pad in carcinoma of the cervix uteri metastatic to the periaortic lymph nodes. Surg Gynecol Obstet 1987;165:503–506.
145.
Kim RY, Levy DS, Brascho DJ, et al. Uterine perforation during intracavitary application: prognostic significance in carcinoma of the cervix. Radiology 1983;147:249–251.
146.
White AJ, Buchsbaum HJ, Blythe JG, et al. Use of the bulbocavernosus muscle (Martius procedure) for repair of radiation-induced rectovaginal fistulas. Obstet Gynecol 1982;60:114–118.
147.
Bricker EM, Johnston WD. Repair of postirradiation rectovaginal fistula and stricture. Surg Gynecol Obstet 1979;148:499–506.
148.
Smith ST, Seski JC, Copeland LJ, et al. Surgical management of irradiation-induced small bowel damage. Obstet Gynecol 1985;65:563–567.
149.
Bloss JD, Blessing JA, Behrens BC, et al. Randomized trial of cisplatin and ifosfamide with and without bleomycin in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 2002;20:1832–1837.
150.
Omura GA, Blessing JA, Vaccarello L, et al. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 1997;15:165.
151.
Moore DH, Blessing JA, McQuellon RP, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. J Clin Oncol 2004;22:3113.
152.
Long HJ, Monk BJ, Huang HQ, et al. Clinical results and quality of life analysis of the MVAC combination in carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 2006;100:537– 543.